Search

Your search keyword '"Chang, Chun-Chao"' showing total 711 results

Search Constraints

Start Over You searched for: Author "Chang, Chun-Chao" Remove constraint Author: "Chang, Chun-Chao"
711 results on '"Chang, Chun-Chao"'

Search Results

2. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan

3. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

8. Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry

12. Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan

15. THU-365 Real-world effectiveness and safety of 8-week glecaprevir/ pibrentasvir for treatment-naïve patients from Taiwan nationwide HCV registry

17. The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan

22. Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan

23. Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)

24. Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

26. The effects of dietary macronutrient composition on resting energy expenditure following active weight loss: A systematic review and meta‐analysis.

28. Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan

29. Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan

37. Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection

39. The impact of HCV cure on glycemic indices in patients using glecaprevir/pibrentasvir from nationwide Taiwan HCV registry

48. Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial

Catalog

Books, media, physical & digital resources